# FDA Inspection 1314180 - Gillson Testing, Inc. - April 15, 2026

Source: https://www.keypedia.com/records/fda_inspections/gillson-testing-inc/6b72596a-1182-4b43-80bf-6ad64568ef1d
Source feed: FDA_Inspections

> FDA Inspection 1314180 for Gillson Testing, Inc. on April 15, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314180
- Company Name: Gillson Testing, Inc.
- Inspection Date: 2026-04-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/gillson-testing-inc/04c29bcd-ddd1-4bac-b34d-b3e74a3c4067

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c